Nonneoplastic Condition: Clinical Trials

18 trials for Nonneoplastic Condition, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 2 unknown, 1 terminated. 4 Phase 1, 4 Phase 2, 3 Phase 3, 2 Not applicable, 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4
Phase 24Completed 3, Unknown 1
Phase 33Completed 2, Unknown 1
Not applicable2Completed 2
Early Phase 11Completed 1

Follow Nonneoplastic Condition: new trials by email Literature Review of Nonneoplastic Condition trials Research Report on Nonneoplastic Condition

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Biomarkers in Blood and Tissue Samples From Patients With Epstein-Barr Virus-Positive Hodgkin Lymphoma
DNA analysis, RNA analysis, cytogenetic analysis - Lymphoma, Nonneoplastic Condition
CompletedChildren's Oncology Group502011-12-012016-05-17
Vaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex With Males
quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine, laboratory biomarker analysis - Anal Cancer, Nonneoplastic Condition
Phase 2CompletedAIDS Malignancy Consortium1492011-06-282020-08-11
Biomarkers in Blood Samples From Patients With HIV Infection and Stage III or Stage IV Hodgkin Lymphoma Undergoing Chemotherapy
DNA analysis, RNA analysis, laboratory biomarker analysis - Lymphoma, Nonneoplastic Condition
TerminatedAIDS Malignancy Consortium12011-06-012020-07-29
Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neoplasia
clinical observation, infrared photocoagulation therapy - Anal Cancer, Neoplasm of Uncertain Malignant Potential
Phase 3CompletedAIDS Malignancy Consortium1202011-04-012020-08-04
T-Lymphocyte Infusion or Standard Therapy in Treating Patients at Risk of Cytomegalovirus Infection After a Donor Stem Cell Transplant
adoptive immunotherapy, alemtuzumab, in vitro-treated peripheral blood lymphocyte therapy - Graft Versus Host Disease, Nonneoplastic Condition
Phase 2UnknownUniversity Hospital Birmingham782009-09-012013-08-26
Study of Blood and Tissue Samples From Patients With Aggressive Non-Hodgkin B-Cell Lymphoma or Hodgkin Lymphoma
polymerase chain reaction, laboratory biomarker analysis - Lymphoma, Nonneoplastic Condition
CompletedAIDS Malignancy Consortium522009-08-012020-08-07
Vaccine Therapy in Preventing HPV in HIV-Positive Women in India
quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine, DNA analysis, polymerase chain reaction - Cervical Cancer, Nonneoplastic Condition
Phase 1CompletedAIDS Malignancy Consortium1502009-08-012024-03-19
S0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III or Stage IV Hodgkin Lymphoma
bleomycin sulfate, filgrastim, ABVD regimen - Lymphoma, Nonneoplastic Condition
Phase 2CompletedSWOG Cancer Research Network3712009-07-012022-08-18
Human Papilloma Virus Infection in HIV-Positive Indian Men Who Have Sex With Men
DNA analysis, polymerase chain reaction, fluorescence activated cell sorting - Nonneoplastic Condition, Precancerous Condition
CompletedAIDS Malignancy Consortium3022009-07-012015-10-05
Comparing Two Types of Swabs in Collecting Cell Samples for Anal Pap Tests and Human Papillomavirus Tests in Men Who Have Sex With Men
Papanicolaou test - Anal Cancer, Nonneoplastic Condition
Not applicableCompletedJonsson Comprehensive Cancer Center482009-03-122020-08-03
Prednisone or Dexamethasone in Newly Diagnosed, Previously Untreated Primary Immune Thrombocytopenic Purpura
dexamethasone, prednisone, quality-of-life assessment - Nonneoplastic Condition
Phase 3CompletedGruppo Italiano Malattie EMatologiche dell'Adulto1502008-04-012017-02-20
Rituximab and Prednisone as First-Line Therapy in Treating Patients With Immune Thrombocytopenic Purpura
Rituximab, Prednisone - Nonneoplastic Condition
Early Phase 1CompletedMayo Clinic222007-01-012014-10-17
Vaccine Therapy in Preventing Cytomegalovirus in Healthy Participants
PADRE-CMV fusion peptide vaccine, tetanus-CMV fusion peptide vaccine, agatolimod sodium - Nonneoplastic Condition
Phase 1CompletedCity of Hope Medical Center682006-12-012012-06-25
Vaccine Therapy, Incomplete Freund's Adjuvant, and GM-CSF in Treating Patients With HIV
E1M184V peptide vaccine, incomplete Freund's adjuvant, sargramostim - Nonneoplastic Condition
Phase 1CompletedNational Institutes of Health Clinical Center (CC)402006-07-012012-05-02
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis
tanespimycin - Chronic Myeloproliferative Disorders, Leukemia
Phase 2CompletedNational Institutes of Health Clinical Center (CC)372006-05-012012-03-15
Combination Chemotherapy Followed By Donor Stem Cell Transplant in Treating Patients With Hemophagocytic Lymphohistiocytosis
anti-thymocyte globulin, busulfan, cyclophosphamide - Nonneoplastic Condition
Phase 3UnknownChildren's Cancer and Leukaemia Group2882006-03-012013-09-17
Vaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer
EBNA1 C-terminal/LMP2 chimeric protein-expressing recombinant modified vaccinia Ankara vaccine, laboratory biomarker analysis, pharmacological study - Gastric Cancer, Head and Neck Cancer
Phase 1CompletedCancer Research UK162005-03-012012-02-28
Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant
ganciclovir, polymerase chain reaction, flow cytometry - Chronic Myeloproliferative Disorders, Leukemia
Not applicableCompletedCity of Hope Medical Center1002000-01-012015-06-08

Narrower conditions

HIV Infections (9)  ·  Lymphoma (7)  ·  Hodgkin Disease (6)  ·  Precancerous Conditions (6)  ·  Papillomavirus Infections (5)  ·  Burkitt Lymphoma (4)  ·  Lymphoma, Large-Cell, Immunoblastic (4)  ·  Anus Neoplasms (3)  ·  Cytomegalovirus Infections (3)  ·  Lymphoma, Large B-Cell, Diffuse (3)  ·  Epstein-Barr Virus Infections (2)  ·  Leukemia (2)  ·  Leukemia, Hairy Cell (2)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (2)  ·  Lymphohistiocytosis, Hemophagocytic (2)

Broader conditions

Immune System Diseases (16)  ·  Infections (15)  ·  Virus Diseases (15)  ·  DNA Virus Infections (12)  ·  Neoplasms (12)  ·  Hemic and Lymphatic Diseases (10)  ·  Tumor Virus Infections (10)  ·  Blood-Borne Infections (9)  ·  Communicable Diseases (9)  ·  Genital Diseases (9)  ·  Immunologic Deficiency Syndromes (9)  ·  Lentivirus Infections (9)  ·  Pathologic Processes (9)  ·  Pathological Conditions, Signs and Symptoms (9)  ·  RNA Virus Infections (9)

Interventions

Polymerase Chain Reaction (6)  ·  Flow Cytometry (3)  ·  Prednisone (3)  ·  Cyclophosphamide (2)  ·  Dexamethasone (2)  ·  Etoposide (2)  ·  Ganciclovir (2)  ·  Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (2)  ·  Peripheral Blood Stem Cell Transplantation (2)  ·  ABVD protocol (1)  ·  Alemtuzumab (1)  ·  Antilymphocyte Serum (1)  ·  Biopsy (1)  ·  Bleomycin (1)  ·  Blotting, Western (1)

Sponsors

AIDS Malignancy Consortium (6)  ·  City of Hope Medical Center (2)  ·  National Institutes of Health Clinical Center (CC) (2)  ·  Cancer Research UK (1)  ·  Children's Cancer and Leukaemia Group (1)  ·  Children's Oncology Group (1)  ·  Gruppo Italiano Malattie EMatologiche dell'Adulto (1)  ·  Jonsson Comprehensive Cancer Center (1)  ·  Mayo Clinic (1)  ·  SWOG Cancer Research Network (1)  ·  University Hospital Birmingham (1)

Countries

United States (11)  ·  United Kingdom (3)  ·  India (1)  ·  Italy (1)  ·  Puerto Rico (1)

Top investigators

Joel Palefsky, MD (3)  ·  John A. Zaia, MD (2)  ·  Antonio T. Fojo, MD, PhD (1)  ·  Ashok Row Kavi (1)  ·  Dilip Mathai, MD (1)  ·  Dorothy Wiley, Ph.D. RN (1)  ·  Frederick Chen, MD (1)  ·  John W. Mellors, MD (1)  ·  Kathleen M. Wyvill, BSN, RN (1)  ·  Kim E. Nichols, MD, BA (1)  ·  Maria Gabriella Mazzucconi, MD (1)  ·  N. Kumarasamy, MD (1)  ·  Neil M Stevens, MD (1)  ·  Nina Wagner-Johnston, MD (1)  ·  Oliver W. Press, MD, PhD (1)

Results publications

PMID 21719601, PMID 22402037, PMID 23595039, PMID 28508728, PMID 30060087, PMID 30658128, PMID 30723079, PMID 31331918, PMID 38231017, PMID 40135712

NIH funding

U01CA121947 (5), P30CA033572 (2), P30CA015083 (1), R01AI058148 (1), R01CA077544 (1), U10CA032102 (1)